Metabolism of diethyl 4-[(4-bromo-2-cyanophenyl)-carbamoyl]benzylphosphonate in the rat.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Xenobiotica; the fate of foreign compounds in biological systems

• Publication date

  1996-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3109/00498259609046755PMID 8879149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Triglycerides--main lipid risk factor for cardiovascular disease in women?

  2009cited by this paper
• Correction of Hypertriglyceridemia with Low High-Density Lipoprotein Cholesterol by the Novel Compound NO-1886, a Lipoprotein Lipase-Promoting Agent, in STZ-Induced Diabetic Rats

  1995cited by this paper
• Anti-atherogenic effectsof a novel compound, NO-1886, in cholesterol-fed New Zealand White rabbits

  1994cited by this paper
• Metabolism of Casodex in laboratory animals.

  1993cited by this paper
• The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis.

  1993cited by this paper
• Plasma triglyceride and coronary heart disease.

  1991cited by this paper
• Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes

  1989cited by this paper
• The triglyceride issue: a view from Framingham.

  1986cited by this paper
• The Role of Circulating Glucose and Triglyceride Concentrations and Their Interactions with Other “Risk Factors” as Determinants of Arterial Disease in Nine Diabetic Population Samples from the WHO Multinational Study

  1983cited by this paper
• Metabolism of beclamide, N-benzyl-3-chloropropionamide, in man.

  1979cited by this paper
• Drug interaction with hepatic microsomal cytochrome.

  1966cited by this paper
• Evidence for biochemically different types of vesicles in the hepatic microsomal fraction.

  1966cited by this paper
• The Dimerization of 2-Amino-5-nitrobenzonitrile

  1960cited by this paper

• Assessment of induction of cytochrome P450 by NO-1886 (ibrolipim), a lipoprotein lipase-promoting agent, in primary cultures of human hepatocytes and in female rat liver.

  2006cites this paper
• Effects of NO-1886 (Ibrolipim), a lipoprotein lipase-promoting agent, on gene induction of cytochrome P450s, carboxylesterases, and sulfotransferases in primary cultures of human hepatocytes.

  2004cites this paper
• Pharmacokinetics and metabolism of NO-1886, a lipoprotein lipase-promoting agent, in cynomolgus monkey

  2003cites this paper
• Phosphonate O-deethylation of [4-(4-bromo-2-cyano-phenylcarbamoyl) benzyl]-phosphonic acid diethyl ester, a lipoprotein lipase-promoting agent, catalyzed by cytochrome P450 2C8 and 3A4 in human liver microsomes.

  2002cites this paper